Technical Analysis for ELVN - Enliven Therapeutics, Inc.

Grade Last Price % Change Price Change
C 25.43 -2.86% -0.75
ELVN closed down 2.86 percent on Wednesday, November 20, 2024, on 55 percent of normal volume. It ran into resistance at its 50 day moving average.
3 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Up Down Down

Date Alert Name Type % Chg
50 DMA Resistance Bearish 0.00%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Lower Bollinger Band Walk Weakness 0.00%
Lower Bollinger Band Walk Weakness -2.86%
Lower Bollinger Band Touch Weakness -2.86%
Oversold Stochastic Weakness -2.86%
NR7 Range Contraction 2.13%
Lower Bollinger Band Walk Weakness 2.13%
Inside Day Range Contraction 2.13%
Lower Bollinger Band Touch Weakness 2.13%

   Recent Intraday Alerts

Alert Time
Down 3% about 18 hours ago
60 Minute Opening Range Breakdown about 21 hours ago
10 DMA Resistance about 21 hours ago
Down 2 % about 21 hours ago
Down 1% about 22 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Enliven Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of small molecule inhibitors to help patients with cancer. Its pipeline of small molecule kinase inhibitors include ELVN-001, which is being evaluated in a Phase 1 clinical trial in adults with chronic myeloid leukemia; and ELVN-002, a Phase 1 clinical trial has been activated to evaluate people with cancers harboring an abnormal HER2 gene. The company is based in Boulder, Colorado.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cancer Protein Kinase Inhibitor Tyrosine Kinase Receptors Her2 Chronic Myeloid Leukemia

Is ELVN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 30.03
52 Week Low 9.84
Average Volume 281,575
200-Day Moving Average 22.02
50-Day Moving Average 26.42
20-Day Moving Average 27.42
10-Day Moving Average 26.44
Average True Range 1.40
RSI (14) 41.18
ADX 25.16
+DI 18.70
-DI 24.49
Chandelier Exit (Long, 3 ATRs) 25.59
Chandelier Exit (Short, 3 ATRs) 27.89
Upper Bollinger Bands 30.52
Lower Bollinger Band 24.32
Percent B (%b) 0.18
BandWidth 22.59
MACD Line -0.47
MACD Signal Line -0.04
MACD Histogram -0.4267
Fundamentals Value
Market Cap 1.05 Billion
Num Shares 41.2 Million
EPS -0.92
Price-to-Earnings (P/E) Ratio -27.64
Price-to-Sales 0.00
Price-to-Book 2.43
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 27.68
Resistance 3 (R3) 27.78 27.13 27.31
Resistance 2 (R2) 27.13 26.56 27.08 27.18
Resistance 1 (R1) 26.28 26.20 25.96 26.18 27.05
Pivot Point 25.63 25.63 25.47 25.58 25.63
Support 1 (S1) 24.78 25.06 24.46 24.68 23.81
Support 2 (S2) 24.13 24.70 24.08 23.68
Support 3 (S3) 23.28 24.13 23.56
Support 4 (S4) 23.18